Related Experiment Video
Updated: May 8, 2026
MicroRNA Expression Profiles of Human iPS Cells, Retinal Pigment Epithelium Derived From iPS, and Fetal Retinal Pigment Epithelium
Published on: June 24, 2014
Inhibitory effect of microRNA-34a on retinal pigment epithelial cell proliferation and migration
Qiang Hou1, Jiang Tang, Zhenlian Wang
1School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Purpose:
Retinal pigment epithelial (RPE) cells play important roles in ophthalmologic diseases such as proliferative vitreoretinopathy, AMD, and diabetic retinopathy. MicroRNA-34a (miR-34a) has been reported to be important in the regulation of cell proliferation, migration, differentiation, and apoptosis. In this study, we explored the effects of miR-34a on RPE cells.
Methods:
The expression level of miR-34a in subconfluent and postconfluent ARPE-19 cells was investigated with quantitative real-time PCR. MicroRNA mimic and small interfering RNA (siRNA) were transiently transfected into RPE cells. Transfected RPE cells were analyzed with WST-1 proliferation assay, and their migration was analyzed with transwell assay and in vitro scratch study. The expression or activation of target proteins was detected by Western blotting.
Results:
MicroRNA-34a was significantly downregulated in subconfluent ARPE-19 cells compared with postconfluent cells. Introduction of miR-34a inhibited the proliferation and migratory ability of RPE cells without obvious cell apoptosis. In miR-34a transfected cells, many important proliferation and/or migration related molecules such as c-Met, CDK2, CDK4, CDK6, E2F1, and phosphorylated-Cdc2 (p-Cdc2) were downregulated. Small interfering RNA designed to target c-Met also inhibited the proliferation and migration of RPE cells and downregulated CDK2, CDK6, E2F1, and p-Cdc2.
Conclusions:
MicroRNA-34a is downregulated in subconfluent RPE cells. MicroRNA-34a can inhibit the proliferation and migration of RPE cells through downregulation of its targets c-Met and other cell cycle-related molecules. Our results indicated that miR-34a is involved in the regulation of RPE cells.
Insights
MicroRNA-34a (miR-34a) is reduced in early-stage retinal pigment epithelial (RPE) cells. Restoring miR-34a inhibits RPE cell proliferation and migration, offering insights into eye disease regulation.
Area of Science:
- Ophthalmology
- Molecular Biology
- Cell Biology
Background:
- Retinal pigment epithelial (RPE) cells are crucial in maintaining retinal health and are implicated in various eye diseases.
- MicroRNA-34a (miR-34a) is a key regulator of cellular processes including proliferation, migration, differentiation, and apoptosis.
Purpose of the Study:
- To investigate the role and effects of miR-34a in RPE cells.
- To determine the expression levels of miR-34a in different RPE cell states.
Main Methods:
- Quantitative real-time PCR to measure miR-34a expression in subconfluent and postconfluent ARPE-19 cells.
- Transfection of RPE cells with miR-34a mimics and small interfering RNA (siRNA).
- Assessment of cell proliferation (WST-1 assay), migration (transwell and scratch assays), and protein expression (Western blotting).
Main Results:
- miR-34a was significantly downregulated in subconfluent RPE cells compared to postconfluent cells.
- Overexpression of miR-34a inhibited RPE cell proliferation and migration without inducing significant apoptosis.
- miR-34a transfection led to the downregulation of key molecules like c-Met, CDK2, CDK4, CDK6, E2F1, and p-Cdc2.
- siRNA targeting c-Met also reduced proliferation and migration, affecting downstream molecules.
Conclusions:
- miR-34a expression is reduced in subconfluent RPE cells, suggesting a role in early disease stages.
- miR-34a acts as an inhibitor of RPE cell proliferation and migration by downregulating targets such as c-Met and cell cycle regulators.
- miR-34a is an important regulator of RPE cell function and a potential therapeutic target for related ophthalmologic diseases.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs